FACCHETTI, GIORGIO
 Distribuzione geografica
Continente #
NA - Nord America 7.818
AS - Asia 7.313
EU - Europa 7.034
SA - Sud America 696
AF - Africa 169
OC - Oceania 44
Continente sconosciuto - Info sul continente non disponibili 5
Totale 23.079
Nazione #
US - Stati Uniti d'America 7.521
SG - Singapore 2.222
IT - Italia 2.197
CN - Cina 1.992
GB - Regno Unito 1.318
DE - Germania 701
BD - Bangladesh 642
SE - Svezia 629
HK - Hong Kong 579
BR - Brasile 544
RU - Federazione Russa 499
VN - Vietnam 475
IN - India 460
FR - Francia 348
IE - Irlanda 257
FI - Finlandia 192
KR - Corea 191
NL - Olanda 183
CA - Canada 182
JP - Giappone 179
ES - Italia 175
DK - Danimarca 156
ID - Indonesia 142
TR - Turchia 125
CH - Svizzera 59
PL - Polonia 58
AT - Austria 56
MX - Messico 53
CI - Costa d'Avorio 50
PK - Pakistan 46
IR - Iran 41
AR - Argentina 40
UA - Ucraina 39
BE - Belgio 37
AU - Australia 36
TW - Taiwan 36
PH - Filippine 30
CO - Colombia 27
ZA - Sudafrica 27
IQ - Iraq 26
CZ - Repubblica Ceca 25
CL - Cile 24
EC - Ecuador 21
MA - Marocco 20
RO - Romania 17
VE - Venezuela 17
IL - Israele 16
EG - Egitto 15
MY - Malesia 14
SA - Arabia Saudita 14
TH - Thailandia 14
DZ - Algeria 13
SC - Seychelles 13
AZ - Azerbaigian 12
CR - Costa Rica 12
GR - Grecia 11
AL - Albania 10
UZ - Uzbekistan 10
HU - Ungheria 9
JM - Giamaica 9
PT - Portogallo 9
TT - Trinidad e Tobago 9
BG - Bulgaria 8
LT - Lituania 8
NZ - Nuova Zelanda 8
PE - Perù 8
NO - Norvegia 7
NP - Nepal 7
GT - Guatemala 6
HN - Honduras 6
PA - Panama 6
JO - Giordania 5
LU - Lussemburgo 5
PY - Paraguay 5
TN - Tunisia 5
UY - Uruguay 5
BO - Bolivia 4
KE - Kenya 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
AE - Emirati Arabi Uniti 3
BZ - Belize 3
CM - Camerun 3
EE - Estonia 3
ET - Etiopia 3
EU - Europa 3
GE - Georgia 3
HR - Croazia 3
KG - Kirghizistan 3
KZ - Kazakistan 3
MV - Maldive 3
NG - Nigeria 3
PS - Palestinian Territory 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BB - Barbados 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
IM - Isola di Man 2
Totale 23.044
Città #
Singapore 1.341
Southend 1.078
Dallas 925
Ashburn 863
Milan 711
San Jose 454
Hong Kong 453
Chandler 415
Fairfield 337
Council Bluffs 321
Beijing 310
Santa Clara 265
Los Angeles 241
Hefei 236
Dublin 222
Seattle 214
Wilmington 212
Frankfurt am Main 209
Houston 195
Ann Arbor 182
New York 176
Woodbridge 163
Princeton 155
Bengaluru 151
Cambridge 150
Ho Chi Minh City 148
Hanoi 120
Helsinki 117
Munich 111
Lauterbourg 109
Jakarta 107
Moscow 103
Boardman 100
Buffalo 100
Seoul 98
Guangzhou 91
Tokyo 90
Bologna 87
Rome 81
Nanjing 75
Naples 67
Dearborn 60
Toronto 57
Columbus 54
Phoenix 54
Redwood City 54
Shanghai 53
Des Moines 52
Istanbul 52
Abidjan 50
São Paulo 45
Padova 43
Florence 42
Berlin 40
Medford 38
The Dalles 38
Shenzhen 37
Hangzhou 36
Kolkata 36
London 36
Nuremberg 35
Karlsruhe 34
Turin 34
Jinan 33
Orem 33
Cangzhou 32
Brescia 30
Rio de Janeiro 30
San Diego 30
Atlanta 29
Brussels 29
Lappeenranta 29
Bergamo 28
Chicago 28
Vienna 28
Tianjin 27
Turku 27
Changsha 26
Fremont 26
Roxbury 25
Wuhan 24
Saint Petersburg 23
Shenyang 23
Warsaw 23
Amsterdam 22
Boston 22
Fuzhou 22
Montreal 22
Da Nang 21
Haiphong 21
Madrid 20
Taipei 20
Pohang 19
Verona 19
Zaragoza 19
Brooklyn 18
Central District 18
Kent 18
Mumbai 18
Zhengzhou 18
Totale 13.463
Nome #
An in vivo active 1,2,5-oxadiazole Pt(II) complex : a promising anticancer agent endowed with STAT3 inhibitory properties 438
Synthesis of new dithiolethione and methanethiosulfonate systems endowed with pharmaceutical interest 429
Amphiphilic Pt(II) complexes for in vivo bioimaging applications 426
Artificial metalloenzymes based on vancomycin for stereoselective catalysis in aqueous media 385
Cytotoxic effect of (1-methyl-1H-imidazol-2-yl)-methanamine and its derivatives in PtII complexes on human carcinoma cell lines: A comparative study with cisplatin 338
Simple 1,3-diamines and their application as ligands in ruthenium(ii) catalysts for asymmetric transfer hydrogenation of aryl ketones 309
Efficient methodology to produce a duloxetine precursor using whole cells of Rhodotorula rubra 308
Water soluble Ir-complexes for ECL signal amplification in pathogens detection 303
Luminescent amphiphilic Pt(II) complexes and their assemblies 300
Self-assembly in vivo: imaging and reactivity 299
Fluorinated dichloride platinum complexes: a new series of promising anticancer agents against orphan tumors 296
Sensitivity of mesenchymal stromal cells to a new imidazole-based cationic Pt(II) complex with high in vitro anticancer activity 296
Conventional and non-conventional catalytic systems for the asymmetric reduction of cyclic imines 296
Novel 3,3-disubstituted oxindole derivatives. Synthesis and evaluation of the anti-proliferative activity 296
Antiproliferative effects of chalcones on T cell acute lymphoblastic leukemia‐derived cells: Role of PKCβ 294
Ruthenium(II) complexes bearing (NNN) ligand : catalytic evaluation of different solvent-mediated coordination modes 290
Novel platinum agents and mesenchymal stromal cells for thoracic malignancies : state of the art and future perspectives 287
Monofunctional Pt(II) complexes based on 8-aminoquinoline: synthesis and pharmacological characterization 282
Self-assembled complex promotes cell proliferation and stem cell self-renewal through redox signaling in in vivo model 279
Cascade Reaction by Chemo- and Biocatalytic Approaches to Obtain Chiral Hydroxy Ketones and anti 1,3-Diols 272
“In situ” Activation of Racemic RuII Complexes: Separation of trans and cis Species and Their Application in Asymmetric Reduction 271
Anticancer platinum(II) complexes bearing N-heterocycle rings 271
Electrochemiluminescent multinuclear metal complexes for diagnostics 269
Exploring the copper binding ability of Mets7 hCtr‐1 protein domain and His7 derivative: An insight in Michael addition catalysis 268
Enantioselective transfer hydrogenation of aryl ketones: synthesis and 2D-NMR characterization of new 8-amino-5,6,7,8-tetrahydroquinoline Ru(II)-complexes 265
Evaluation of chemical diversity of biotinylated chiral 1,3-diamines as a catalytic moiety in artificial imine reductase 264
Malignant Pleural Mesothelioma : State of the art and advanced cell therapy 258
Cytotoxic platinum(II) complexes bearing N-heterocycle rings as novel theranostic agents 254
Anticancer platinum‑drug delivered by mesenchymal stromal cells improves its activity on glioblastoma 252
Alternative Strategy to Obtain Artificial Imine Reductase by Exploiting Vancomycin/D-Ala-D-Ala Interactions with an Iridium Metal Complex 252
Vancomycin-Iridium (III) Interaction: An Unexplored Route for Enantioselective Imine Reduction 252
Uptake-release by MSCs of a cationic platinum(II) complex active in vitro on human malignant cancer cell lines 251
One-pot catalytic strategies for the efficient and enantioselective synthesis of L-Carnosine 250
Catalytic Applications for Heavy Metals Bio-recovery 248
Luminescent self-assemblies of Pt(II) complexes in vivo 246
Luminescent water-soluble cycloplatinated complexes: structural, photophysical, electrochemical and chiroptical properties 241
Promising antiproliferative platinum(II) complexes based on imidazole moiety: synthesis, evaluation in HCT-116 cancer cell line and interaction with Ctr-1 Met-rich domain 240
Synthesis and crystallographic structure of nickel(0) carbonyl complex with Bitianp, an atropoisomeric diphosphine 240
In vitro anticancer activity evaluation of new cationic platinum(II) complexes based on imidazole moiety 238
8-Amino-5,6,7,8-tetrahydroquinoline in iridium(iii) biotinylated Cp* complex as artificial imine reductase 237
Enhancing Pt (IV) Complexes Anticancer Activity Upon Encapsulation in Stimuli Responsive Nanocages 233
Cationic platinum(II) complexes active in vivo as anticancer drugs 233
8-Amino-5,6,7,8-Tetrahydroquinolines as Ligands in Iridium(III) Catalysts for the Reduction of Aryl Ketones by asymmetric transfer hydrogenation (ATH) 225
Cationic Pt(II) complex based on 8-aminoquinoline: in vitro activity against human glioblastoma 222
Ni²⁺ and Cu²⁺ Biosorption by EPS-Producing Serratia plymuthica Strains and Potential Bio-Catalysis of the Organo–Metal Complexes 218
8-Amino-5,6,7,8-tetrahydroquinolines as ligands in iridium(III) catalysts for the reduction of aryl ketones by asymmetric transfer hydrogenation (ATH) 214
The mesenchymal stromal cells increased the activity on glioblastoma of a new delivered anticancer platinum-drug 204
Combined chemical and biocatalytic approach for asymmetric one-pot reactions 203
New sp3 diphosphine-based rhodium catalysts for the asymmetric conjugate addition of aryl boronic acids to 3-azaarylpropenones 202
Hybrid Catalysts from Copper Biosorbing Bacterial Strains and Their Recycling for Catalytic Application in the Asymmetric Addition Reaction of B2(pin)2 on α,β-Unsaturated Chalcones 202
One-pot reactions in catalysis: a valuable tool for the synthesis of enantiopure intermediates for pharmaceutical applications 197
Promising Non-cytotoxic Monosubstituted Chalcones to Target Monoamine Oxidase‑B 197
Chemo- and biocatalytic strategies to obtain phenylisoserine, lateral chain of taxol by asymmetric reduction 196
Nonabsorbable Iron(III) binding polymers : Synthesis and evaluation of the chelating properties 196
Diastereoselectivity and catalytic activity in ruthenium complexes chiral at the metal centre 194
Highly efficient morpholine-based organocatalysts for the 1,4-addition reaction between aldehydes and nitroolefins: an unexploited class of catalysts 192
Mets7 motif peptides in coordinative Cu(I) complexes: application in asymmetric Henry reaction 192
Synthesis and anticancer activity of cyclometalated Pt(II) neutral complexes containing curcumin as a bioactive ancillary ligand 191
Amphiphilic Pt(II) complex for in vivo imaging applications 191
In Vitro Activity of Monofunctional Pt-II Complex Based on 8-Aminoquinoline against Human Glioblastoma 190
New Mets7 motif metallopeptide catalysts for Cu(I)-catalyzed asymmetric Henry reaction 188
Biological Properties of New Chiral 2-Methyl-5,6,7,8-tetrahydroquinolin-8-amine-based Compounds 183
Exploitation of Dimeric Cyclic Cysteine as Helix Inducer in Ultra‐Short Peptides for Cu(II)‐Catalyzed Asymmetric Michael Addition on Chalcones 182
STAT3 direct inhibitors: from MD77 to AC33 181
An oxadiazole Pt(II) complex with promising in vivo antitumor activity 181
Aminoquinoline-based Ruthenium catalyst for reduction of ketones by hydrogen transfer 180
Stimuli-responsive luminophore drives mechanism switch for highly efficient electrochemiluminescence immunosensing 178
"In situ" activation of racemic Ru(II) complexes : separation of trans and cis species and their application in asymmetric reduction 177
Asymmetric Hydrogenation of 1-aryl substituted-3,4-Dihydroisoquinolines with Iridium Catalysts Bearing Different Phosphorus-Based Ligands 177
Alizarin as a selective carrier in cytotoxic Pt(II) complexes toward Triple Negative Breast Cancer (TNBC) 176
Recycling of copper contaminants from wastewater as new hybrid catalysts for the synthesis of valuable pharmaceutical intermediates 175
A new artificial reductase based on the D-Ala-D-Ala/Vancomycin supramolecular interaction and its applications in the enantioselective reduction of cyclic imines 175
Oxadiazole Pt(II) complexes: promising STAT3 inhibitors in cancer therapy 173
A new series of fluorinated dichloride platinum complexes as promising anticancer agents against orphan tumors 173
Ctr-1 Mets7 motif inspiring new peptide ligands for Cu(i)-catalyzed asymmetric Henry reactions under green conditions 169
Asymmetric Hydrogenation vs Transfer Hydrogenation in the Reduction of Cyclic Imines 166
Cytotoxic performances of new anionic cyclometalated Pt(II) complexes bearing chelated O^O ligands 161
Sintesi stereoselettiva di ammine cicliche di interesse farmaceutico mediata da catalizzatori ibridi 160
Catalytic strategies for the synthesis of carnosine derivatives 158
Double approaches for obtaining an asymmetric one-pot addition/reduction reaction 156
New Platinum(II) complexes in STAT3 inhibition: a promising tool for anticancer therapy 156
Amphiphilic Pt(II) complex for in vivo imaging applications 152
Chiral 8-Amino-5,6,7,8-tetrahydroquinoline Derivatives in Metal Catalysts for the Asymmetric Transfer Hydrogenation of 1-Aryl Substituted-3,4-dihydroisoquinolines as Alkaloids Precursors 152
New 1,2,5-oxadiazole Pt(II)complex endowed with STAT3 inhibitory properties as promising anticancer agent 151
New hybrid imine reductases based on Vancomycin for the asymmetric reduction of cyclic imines in aqueous buffer 151
Fluorine activation of promising platinum compounds as anticancer drugs against orphan tumors 150
Sensitivity of human glioblastoma to a new monofunctional PT-II compex based on 8-aminoquinoline 150
Curcumin-based ionic Pt(ii) complexes: antioxidant and antimicrobial activity 149
One-pot chemoenzymatic synthesis of enantiopure aryl- and alkyl-azaarenes pharmaceutical intermediates 148
New fluorinated platinum compounds as promising anticancer warriors against orphan tumors 145
Asymmetric reduction of cyclic imines by a new hybrid catalyst based on an iridium-vancomycin system 141
Hybrid Metal Catalysts as Valuable Tools in Organic Synthesis: An Overview of the Recent Advances in Asymmetric C–C Bond Formation Reactions 140
Reproducible Ala-Gly oligomerization catalyzed by the natural Borate colemanite in prebiotic conditions 140
Breakable nanomaterials to allow hair coloring with natural dyes 139
New rhodium-sp3 diphosphine catalytic systems for the asymmetric addition of aryl boronic acids to azaarenes 138
Design, synthesis, and biological evaluation of chalcone derivatives as selective Monoamine Oxidase-B inhibitors with potential neuroprotective effects 137
Asymmetric one-pot reaction matching chemical and biocatalytic approaches 136
A novel series of monofunctional Pt(II) complexes framed on 8-aminoquinoline: synthesis and antiproliferative studies 135
Theragnostic neutral Pt(II) complexes based on 8-aminoquinoline skeleton 132
Cytotoxic Pt(ii) complexes containing alizarin: a selective carrier for DNA metalation 132
Totale 21.925
Categoria #
all - tutte 68.139
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.139


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.858 166 92 81 132 123 139 151 114 245 115 140 360
2022/20231.998 258 184 189 154 195 295 68 146 192 49 175 93
2023/20241.541 73 121 87 103 270 90 124 132 44 96 195 206
2024/20254.005 169 324 209 432 333 240 239 365 206 329 413 746
2025/202610.077 844 764 1.465 820 878 623 1.091 421 864 511 963 833
2026/2027309 309 0 0 0 0 0 0 0 0 0 0 0
Totale 23.930